CLARE Butler struggled with her weight for most of her adult life. As an emotional eater, food was her go-to whenever she felt sad, happy, stressed, or angry.  But after turning to fat jabs, ...

Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels ...

The Medicines and Healthcare products Regulatory Agency has issued an alert regarding contraception and weight loss and ...

Dizziness, sudden hunger, or easy anger? Could be a sign of low blood sugar. Recognize these 5 symptoms before it's too late!

Drugs that promise rapid and effortless weight loss once seemed like the stuff of fairytales. Now, even if we’re not “on the ...

Mounjaro, one of the brand names for tirzepatide, is a drug that is beneficial for people with type 2 diabetes. This ...

Dr. Reddy's faces revenue slowdown post gRevlimid boost, but new investments and partnerships offer long-term growth ...

The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...

With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in ...

The law will go into effect on Oct. 1. House Bill 597 gives school districts, and individual schools, the ability to maintain a supply of glucagon so they can respond during an emergency situation ...

Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...